Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
Conditions: DLBCL - Diffuse Large B Cell Lymphoma Interventions: Drug: Dexrazoxane; Drug: Rituximab; Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Vincristine; Drug: Prednisolone; Drug: Lenalidomide Sponsors: Stichting Hemato-Oncologie voor Volwassenen Nederland; UMC Utrecht; Amsterdam University Medical Centers; The Dutch Network for Cardiovascular Research (WCN) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Physical Exercise, Diet, and Health in People With Type 2 Diabetes: Longitudinal Design of the EDUGUTION Study
Conditions: Fat Burn; Diabetes Mellitus, Type 2; Cardiovascular Diseases; Metabolism Disorder Interventions: Other: No intervention Sponsors: University of Cadiz; Ministerio de Ciencia e Innovaci ón, Spain Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
Conditions: Cardiovascular Interventions: Drug: AZD1705; Other: Placebo Sponsors: AstraZeneca; Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
The Effects of Healthy Diets With Plant Oils on Heart and Metabolic Health
Conditions: Cardiovascular Diseases Interventions: Other: Healthy Dietary Pattern with Cottonseed Oil; Other: Healthy Dietary Pattern with Fatty Acid-Matched Plant Oils; Other: Healthy Dietary Pattern with PUFA:SFA Ratio-Matched Plant Oil Sponsors: Penn State University; Cotton Incorporated Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Personalised Hyperlipidaemia Therapies Guided by Pharmacogenomics
Conditions: Cardiovascular Diseases Interventions: Other: Pharmacogenomics-directed Hyperlipidaemia Management Sponsors: National University of Singapore; Collabring Consultancy Pte Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)
Conditions: Heart Failure; Heart Failure With Reduced Ejection Fraction; Cardiovascular Diseases; Heart Diseases Interventions: Drug: Tovinontrine (CRD-750); Drug: Placebo Sponsors: Cardurion Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
The Effect of Polymorphism of the GUCY1A3 rs7692387 Gene on Cardiovascular Events After Coronary Artery Bypass Grafting.
Conditions: to Evaluate the Association of GUCY1A3 rs7692387 Gene Polymorphism Carrier on the Development of Cardiovascular Events After Coronary Artery Bypass Grafting Interventions: Genetic: coronary artery bypass grafting Sponsors: Novosibirsk Scientific Research Institute for Circulatory Pathology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Effect of Vibration and Cold Application on Chest Tube Removal Pain After CABG
Conditions: Pain, Procedural; Pain, Postoperative; Coronary Artery Bypass Surgery; Chest Tubes Interventions: Device: Vibration device; Other: Vibration device&Cold application pack Sponsors: Istanbul University - Cerrahpasa (IUC); Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
Conditions: Heart Failure; Heart Failure Preserved Ejection Fraction; Cardiovascular Diseases; Heart Diseases Interventions: Drug: Tovinontrine (CRD-750; Drug: Placebo Sponsors: Cardurion Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
Conditions: Paroxysmal Atrial Fibrillation Interventions: Behavioral: Self- Report Evaluation-Duke Activity Status Index; Behavioral: Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire; Diagnostic Test: Cardiopulmonary exercise test (CPET); Diagnostic Test: Transthoracic echocardiogram; Diagnostic Test: Ambulatory cardiac rhythm assessment; Diagnostic Test: Cardiovascular magnetic resonance (CMR) Sponsors: Virginia Commonwealth University; National Heart, Lung, and Blood Institute (NHLBI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
The 5th Generation Tele-Robotic-Assisted Percutaneous Coronary Intervention: A First-in-Human Trial
Conditions: Coronary Artery Disease; Myocardial Ischemia; Cardiovascular Diseases; Coronary Disease; Arteriosclerosis Interventions: Device: 5G Tele-Robotic-Assisted PCI Sponsors: Yan ' an Affiliated Hospital of Kunming Medical University; Shanghai Zhongshan Hospital; Kunming Chenggong District People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Cardiovascular And Metabolic Risk After Arthroplasty
Conditions: Osteoarthritis of the Knee; Osteoarthritis of the Hip; Cardiovascular Diseases; Metabolic Syndrome Interventions: Procedure: Total joint arthroplasty Sponsors: University of Tartu; Tartu University Hospital; Estonian Science Foundation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
Conditions: Cardiovascular Diseases Interventions: Other: Cardiac rehabilitation Sponsors: University of Castilla-La Mancha; Hospital Virgen de la Luz Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
Conditions: Cardiovascular Diseases; Metabolic Syndrome; Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Digital wearable and AI-human symbiotic lifestyle intervention Sponsors: National University Hospital, Singapore; National University of Singapore Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF
Conditions: Heart Failure With Preserved Ejection Fraction; Cardiovascular Morbidity Sponsors: University Medical Center Goettingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
